Predictions
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.66
12.12.21
12.12.21
-
12.12.22
12.12.22
-1.27%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€2.48
12.12.21
12.12.21
-
12.12.22
12.12.22
25.48%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€2.49
12.12.21
12.12.21
-
12.12.22
12.12.22
4.74%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€3.49
21.12.21
21.12.21
-
21.12.22
21.12.22
7.56%
25.12.21
25.12.21
Risky Investment
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€12.89
12.12.21
12.12.21
-
12.12.22
12.12.22
7.45%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Radius Health Inc.
Start price
Target price
Perf. (%)
€6.70
12.12.21
12.12.21
-
12.12.22
12.12.22
-5.19%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€14.95
12.12.21
12.12.21
-
12.12.22
12.12.22
1.10%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€32.60
16.12.21
16.12.21
-
16.12.22
16.12.22
38.19%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
11.12.21
11.12.21
€30.00
11.12.22
11.12.22
8.73%
25.12.21
25.12.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Formycon AG
Start price
Target price
Perf. (%)
€66.90
18.04.21
18.04.21
-
18.04.22
18.04.22
-16.59%
21.12.21
21.12.21
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€16.08
24.06.21
24.06.21
€4.80
24.06.22
24.06.22
-60.12%
20.12.21
20.12.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
CytoDyn Inc_INT
Start price
Target price
Perf. (%)
€1.28
10.07.21
10.07.21
€0.80
10.07.22
10.07.22
-30.80%
20.12.21
20.12.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Oramed Pharmaceuticals
Start price
Target price
Perf. (%)
€23.30
04.11.21
04.11.21
€10.00
04.11.23
04.11.23
-42.83%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€12.34
13.09.21
13.09.21
€9.00
13.09.22
13.09.22
100.65%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Aptose Biosciences
Start price
Target price
Perf. (%)
€3.22
11.06.21
11.06.21
€4.00
11.06.22
11.06.22
-69.57%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.95
11.11.21
11.11.21
€30.00
11.11.22
11.11.22
-21.68%
14.12.21
14.12.21
Could be worthwhile Investment >10% per year
Nanostr.technol.
Start price
Target price
Perf. (%)
€57.50
13.12.20
13.12.20
-
13.12.21
13.12.21
-41.91%
14.12.21
14.12.21
Risky Investment
PhaseBio Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.60
12.12.20
12.12.20
-
12.12.21
12.12.21
-42.22%
13.12.21
13.12.21
Probably not worthwhile Investment
MacroGenics Inc.
Start price
Target price
Perf. (%)
€14.88
05.12.21
05.12.21
-
05.12.22
05.12.22
0.47%
12.12.21
12.12.21
Risky Investment
Radius Health Inc.
Start price
Target price
Perf. (%)
€7.05
08.12.21
08.12.21
-
08.12.22
08.12.22
-4.99%
12.12.21
12.12.21
Risky Investment
Fennec Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.22
29.11.21
29.11.21
-
29.11.22
29.11.22
-16.11%
12.12.21
12.12.21
Could be worthwhile Investment >10% per year
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€39.25
30.11.21
30.11.21
-
30.11.22
30.11.22
-17.83%
12.12.21
12.12.21
Probably not worthwhile Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€17.00
28.11.21
28.11.21
-
28.11.22
28.11.22
7.65%
11.12.21
11.12.21
Could be worthwhile Investment >10% per year
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€14.52
01.12.21
01.12.21
-
01.12.22
01.12.22
-11.23%
11.12.21
11.12.21
Could be very worthwhile Investment >20% year